| Insiders | Shares | % | Avg Price | Total $ | |
|---|---|---|---|---|---|
| Buys | 1 | +50K | 100% | $2.53 | +$127K |
| Sells | 0 | ||||
| Net | +1 | +50K | 100% | +$127K |
| Name | Relationship | Holdings Value | Past Year Net Change | Change % | Report Date |
|---|---|---|---|---|---|
| Craig Shore | CFO and CAO | $2.23M | Jan 23, 2024 | ||
| Shane Gleason | Chief Commercial Officer | $1.3M | Jan 23, 2024 | ||
| Andrea Tommasoli | Chief Operating Officer | $1.25M | Jan 23, 2024 | ||
| Paul Stuka | Director | $895K | Jun 5, 2024 | ||
| Gary S. Roubin | Director | $694K | +$127K | +22.3% | May 28, 2024 |
| Patrick Verta | EVP Clinical/Medical Affairs | $578K | Jan 23, 2024 | ||
| Michael Berman | Director | $575K | Jun 24, 2024 | ||
| Kathryn Arnold | Director | $544K | Jan 23, 2024 | ||
| Thomas J. Kester | Director | $452K | May 28, 2024 | ||
| Campbell Rogers | Director | $70.8K | Oct 13, 2021 | ||
| Marvin Slosman | CEO and President, Director | Jan 23, 2024 |
| Insider | Symbol | Class | Transaction | % | Value $ | * Price $ | Shares | Shares Owned | Date | Ownership |
|---|